Submission for OMB Review; 30-Day Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (National Institute Allergy and Infectious Diseases), 24408-24409 [2025-10491]
Download as PDF
<![CDATA[
24408
Federal Register / Vol. 90, No. 110 / Tuesday, June 10, 2025 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments received are subject to
public disclosure. In general, comments
received will be made available without
change and will not be modified to
remove personal or business
information including confidential,
contact, or other identifying
information. Comments should not
include any information such as
confidential information that would not
be appropriate for public disclosure.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than June 25, 2025.
A. Federal Reserve Bank of Atlanta
(Erien O. Terry, Assistant Vice
President) 1000 Peachtree Street, NE,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
1. Danielle R. Bush, individually, and
as trustee of the Danielle R. Bush
Revocable Trust both of Bethesda,
Maryland; Dorothea Bush Frye and
Laurence W. Frye, individually and as
co-trustees of the Dorothea Bush Frye
Revocable Trust and the Laurence W.
Frye Revocable Trust, all of Fort
Lauderdale, Florida; to retain voting
shares of Franklin Bancshares, Inc., and
thereby indirectly retain voting shares of
Bank of Franklin, both of Meadville,
Mississippi.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Associate Secretary of the Board.
[FR Doc. 2025–10499 Filed 6–9–25; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery
(National Institute Allergy and
Infectious Diseases)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30 days of the date of this
publication.
SUMMARY:
To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Sarah Hijaz,
Health Science Policy Analyst, Office of
Strategic Planning, Initiative
Development and Analysis, 5601
Fishers Lane, Rockville, Maryland
20892 or call non-toll-free number (301)
761–7790 or email your request,
including your address to: sarah.hijaz@
nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on November 29, 2024 (89 FR
94750) and allowed 60 days for public
comment. One public comment was
received. The purpose of this notice is
to allow an additional 30 days for public
comment.
FOR FURTHER INFORMATION CONTACT:
The National Institute of Allergy and
Infectious Diseases (NIAID), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery (NIAID), 0925–0668,
Expiration Date 07/31/2025,
EXTENSION, National Institute of
Allergy and Infectious Diseases (NIAID).
Need and Use of Information
Collection: There are no changes being
requested for this submission. The
proposed information collection activity
provides a means to garner qualitative
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with the Administration’s
commitment to improving service
delivery. By qualitative feedback we
mean information that provides useful
insights on perceptions and opinions
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide information
about the NIAID’s customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
NIAID and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours over
3 years are 7,200 (2,400 per year).
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of collection
Customer satisfaction surveys .................................................................................
In-Depth Interviews (IDIs) or Small Discussion Groups ..........................................
Individual Brief Interviews ........................................................................................
VerDate Sep<11>2014
17:53 Jun 09, 2025
Jkt 265001
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Annual
frequency
per response
4,000
20
40
E:\FR\FM\10JNN1.SGM
1
1
1
10JNN1
Hours per
response
30/60
90/60
15/60
Total hours
2,000
30
10
24409
Federal Register / Vol. 90, No. 110 / Tuesday, June 10, 2025 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Type of collection
Hours per
response
Total hours
Focus Groups ..........................................................................................................
Pilot testing surveys .................................................................................................
Conferences and Training Pre- and Post-surveys ..................................................
Website or Software Usability Tests .......................................................................
30
20
500
20
1
1
1
1
2
30/60
30/60
2
60
10
250
40
Total ..................................................................................................................
4,630
4,630
....................
2,400
Dated: June 4, 2025.
Brandie K. Taylor Bumgardner,
Project Clearance Liaison, National Institute
of Allergy and Infectious Diseases, National
Institutes of Health.
[FR Doc. 2025–10491 Filed 6–9–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
ddrumheller on DSK120RN23PROD with NOTICES1
Annual
frequency
per response
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowships
and Mentored Training: Gastroenterology and
Related Disciplines.
Date: July 10–11, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, 6707
Democracy Boulevard, Rm. 7011, Bethesda,
MD 20892–5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Infectious Diseases and
Immunology B Review Panel.
Date: July 10, 2025.
Time: 10:00 a.m. to 7:00 p.m.
VerDate Sep<11>2014
17:53 Jun 09, 2025
Jkt 265001
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Seyhan Boyoglu Barnum,
Ph.D., Scientific Review Officer, The Center
for Scientific Review, The National Institutes
of Health, 6701 Rockledge Drive, Bethesda,
MD 20892, seyhan.boyoglu-barnum@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Infectious Diseases and
Immunology B Review Panel.
Date: July 10–11, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Diana Maria Ortiz-Garcia,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–5614, diana.ortiz-garcia@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Topics in Biophysics and
Biochemistry.
Date: July 10–11, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Dennis Pantazatos, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–2381, dennis.pantazatos@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
24–011: Pilot Projects to Enhance Utility and
Usage of Data Sets from the Molecular
Transducers of Physical Activity Consortium
(MoTrPAC).
Date: July 10, 2025.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
PO 00000
Frm 00028
Fmt 4703
Sfmt 9990
Contact Person: Chiguang Feng, Ph.D.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Substance Use Disorders.
Date: July 11, 2025.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Meysam Yazdankhah,
Ph.D., Scientific Review Officer, National
Institutes of Health, National Institute on
Drug Abuse, Scientific Review Branch, 11601
Landsdown Street, 3WF, Room Hoteling,
Rockville, MD 20852, (301) 402–6965,
meysam.yazdankhah@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Human
Psychopathology and developmental
disabilities.
Date: July 11, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Rajasri Roy, Ph.D.,
Scientific Review Officer, SRB Scientific
Review Branch, National Institute on Aging,
5601 Fishers Lane, Suite 8B, Rockville, MD
20892, (301) 496–6477, rajasri.roy@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 5, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–10490 Filed 6–9–25; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\10JNN1.SGM
10JNN1
]]>Agencies
[Federal Register Volume 90, Number 110 (Tuesday, June 10, 2025)]
[Notices]
[Pages 24408-24409]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-10491]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Generic
Clearance for the Collection of Qualitative Feedback on Agency Service
Delivery (National Institute Allergy and Infectious Diseases)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Sarah Hijaz, Health Science Policy Analyst,
Office of Strategic Planning, Initiative Development and Analysis, 5601
Fishers Lane, Rockville, Maryland 20892 or call non-toll-free number
(301) 761-7790 or email your request, including your address to:
sarah.hijaz@ nih.gov.
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on November 29, 2024 (89
FR 94750) and allowed 60 days for public comment. One public comment
was received. The purpose of this notice is to allow an additional 30
days for public comment.
The National Institute of Allergy and Infectious Diseases (NIAID),
National Institutes of Health, may not conduct or sponsor, and the
respondent is not required to respond to, an information collection
that has been extended, revised, or implemented on or after October 1,
1995, unless it displays a currently valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: Generic Clearance for the Collection of
Qualitative Feedback on Agency Service Delivery (NIAID), 0925-0668,
Expiration Date 07/31/2025, EXTENSION, National Institute of Allergy
and Infectious Diseases (NIAID).
Need and Use of Information Collection: There are no changes being
requested for this submission. The proposed information collection
activity provides a means to garner qualitative customer and
stakeholder feedback in an efficient, timely manner, in accordance with
the Administration's commitment to improving service delivery. By
qualitative feedback we mean information that provides useful insights
on perceptions and opinions but are not statistical surveys that yield
quantitative results that can be generalized to the population of
study. This feedback will provide information about the NIAID's
customer or stakeholder perceptions, experiences and expectations,
provide an early warning of issues with service, or focus attention on
areas where communication, training or changes in operations might
improve delivery of products or services. These collections will allow
for ongoing, collaborative and actionable communications between the
NIAID and its customers and stakeholders. It will also allow feedback
to contribute directly to the improvement of program management.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours over 3 years are 7,200 (2,400 per year).
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Annual
Type of collection Number of frequency per Hours per Total hours
respondents response response
----------------------------------------------------------------------------------------------------------------
Customer satisfaction surveys.......................... 4,000 1 30/60 2,000
In-Depth Interviews (IDIs) or Small Discussion Groups.. 20 1 90/60 30
Individual Brief Interviews............................ 40 1 15/60 10
[[Page 24409]]
Focus Groups........................................... 30 1 2 60
Pilot testing surveys.................................. 20 1 30/60 10
Conferences and Training Pre- and Post-surveys......... 500 1 30/60 250
Website or Software Usability Tests.................... 20 1 2 40
--------------------------------------------------------
Total.............................................. 4,630 4,630 ........... 2,400
----------------------------------------------------------------------------------------------------------------
Dated: June 4, 2025.
Brandie K. Taylor Bumgardner,
Project Clearance Liaison, National Institute of Allergy and Infectious
Diseases, National Institutes of Health.
[FR Doc. 2025-10491 Filed 6-9-25; 8:45 am]
BILLING CODE 4140-01-P
